Ramsey M W, Goodfellow J, Jones C J, Luddington L A, Lewis M J, Henderson A H
Department of Cardiology, University of Wales College of Medicine, Heath Park, Cardiff, UK.
Circulation. 1995 Dec 1;92(11):3212-9. doi: 10.1161/01.cir.92.11.3212.
Vascular tone is a determinant of conduit artery distensibility. The aim of this study was to establish whether endothelium-derived relaxing factor (EDRF) influences the distensibility of conduit arteries and whether endothelium-mediated increases in distensibility are impaired in chronic heart failure (CHF).
Conduit artery distensibility was measured by two methods in healthy subjects and in nine patients with CHF caused by dilated cardiomyopathy. In the first method, pulse-wave velocity (PWV) was measured in the right common iliac artery at rest and during local infusions of acetylcholine (10(-7) to 10(-5) mol/L) or adenosine (2 x 10(-7) to 2 x 10(-5) mol/L), with correction for systemic effects. Acetylcholine induced concentration-dependent local reductions of PWV in healthy subjects (-5%, -15%, and -26%) but not in CHF patients (3%, 1%, -4%, P < .01), whereas adenosine induced similar reductions of PWV in healthy subjects and CHF patients. In the second method, brachial artery diameter, blood flow, and blood pressure were measured noninvasively by high-resolution ultrasound, continuous-wave Doppler, and photoplethysmography during reactive hyperemia in the hand and after sublingual glyceryl trinitrate (GTN, 400 micrograms). Hyperemic flow, similar in healthy subjects and CHF patients, was associated with increases in diameter and distensibility in healthy subjects (8.8% and 18.4%, respectively) but not in CHF patients (0.3% and -4.5%), whereas GTN induced similar effects in healthy subjects and CHF patients.
These data indicate that conduit artery distensibility is increased by acetylcholine and increased blood flow in healthy subjects but not in CHF patients, whereas the effects of adenosine and GTN on distensibility are preserved in CHF patients. This implies that EDRF-mediated increases in distensibility are impaired in CHF patients, thus adding to cardiac work.
血管张力是传导动脉扩张性的一个决定因素。本研究的目的是确定内皮源性舒张因子(EDRF)是否影响传导动脉的扩张性,以及在慢性心力衰竭(CHF)中内皮介导的扩张性增加是否受损。
采用两种方法测量健康受试者以及9例扩张型心肌病所致CHF患者的传导动脉扩张性。第一种方法是,在静息状态下以及局部输注乙酰胆碱(10⁻⁷至10⁻⁵mol/L)或腺苷(2×10⁻⁷至2×10⁻⁵mol/L)期间,测量右髂总动脉的脉搏波速度(PWV),并校正全身效应。乙酰胆碱可使健康受试者的PWV出现浓度依赖性的局部降低(-5%、-15%和-26%),但CHF患者则无此变化(3%、1%、-4%,P<0.01),而腺苷可使健康受试者和CHF患者的PWV出现类似程度的降低。第二种方法是,在手部反应性充血期间以及舌下含服硝酸甘油(GTN,400μg)后,通过高分辨率超声、连续波多普勒和光电容积描记法无创测量肱动脉直径、血流量和血压。健康受试者和CHF患者的充血性血流相似,健康受试者的充血性血流与直径增加和扩张性增加相关(分别为8.8%和18.4%),但CHF患者则不然(0.3%和-4.5%),而GTN在健康受试者和CHF患者中产生类似的效应。
这些数据表明,乙酰胆碱和血流量增加可使健康受试者的传导动脉扩张性增加,但CHF患者则不然,而腺苷和GTN对扩张性的影响在CHF患者中得以保留。这意味着CHF患者中EDRF介导的扩张性增加受损,从而增加了心脏负荷。